Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when REGENXBIO Inc. publishes a filing, an earnings call transcript or a press release.

Get RGNX alerts

About Ken Mills

Ken Mills is recorded as CEO at REGENXBIO Inc. (RGNX). Ken Mills has spoken on 15 earnings calls and 1 other investor event across 1 company, most recently for REGENXBIO Inc. on September 15, 2026. REGENXBIO Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at REGENXBIO Inc. includes Curran M. Simpson (CEO, COO and Board Member), Allan M. Fox (Chairman and Board Member), George Migausky (Chairman and Board Member) and 7 others.

Ken Mills on recent calls

“We've been in business for roughly 15 years. working on AAV, primarily AAV8 and AAV9 as the base capsids that we've been innovating on. The company is really divided into two different areas.”
CEO, BAIRD 2026 GLOBAL HEALTHCARE CONFERENCE ·
“I’m pleased to begin today’s call with a recap of our recent business highlights as well as an update on our corporate goals.”
CEO, REGENXBIO Inc. Q4 FY2023 Earnings Call ·
“I'm pleased to begin today's call with an explanation of our updated strategic plan. Dr. Steve Pakola, our Chief Medical Officer, will then provide an update on our clinical programs.”
CEO, REGENXBIO Inc. Q3 FY2023 Earnings Call ·
“I'm pleased to begin today's call with a recap of some recent business highlights, as well as an update on our corporate goals.”
CEO, REGENXBIO Inc. Q2 FY2023 Earnings Call ·
“I'm pleased to begin today's call by recapping our recent business highlights as well as providing an update on our corporate goals.”
CEO, REGENXBIO Inc. Q1 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at REGENXBIO Inc.

Recent activity